ALZpath: Funding, Investors & Team (Sep 2026)
ALZpath is a biotech organization that offers innovative diagnostic options for Alzheimer's disease.
ALZpath has raised $8.4M across 2 funding rounds on record, the most recent an undisclosed round of $8.4M announced in Jul 2026.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ALZpath Company Profile and Key Stats
Latest funding round on record: Jul 2026.
ALZpath Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
ALZpath announced an undisclosed round in Jul 2023; the amount was not disclosed.
3 years later, an undisclosed round of $8.4M was announced in Jul 2026.
ALZpath Investors
ALZpath Founders and Leadership Team
Contact details for the ALZpath team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →ALZpath Funding Compared to Other Biotechnology Startups
ALZpath's latest round of $8.4M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ALZpath in Biotechnology and Carlsbad
Companies Similar to ALZpath
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
ALZpath Funding FAQs
What does ALZpath do?
ALZpath is a biotech organization that offers innovative diagnostic options for Alzheimer's disease.
How much funding has ALZpath raised?
ALZpath has raised $8.4M across 2 rounds on record. The most recent is an undisclosed round of $8.4M announced in Jul 2026.
When did ALZpath last raise funding?
ALZpath's most recent funding round on record is an undisclosed round of $8.4M, announced in Jul 2026.
Who has invested in ALZpath?
Investors on record for ALZpath include Alzheimer's Drug Discovery Foundation, Gareth DeSanctis.
Who founded ALZpath?
FundedIQ lists Julie Reisetter (Founder) at ALZpath.
Who is the CEO of ALZpath?
Mike Banville is listed as Chief Executive Officer at ALZpath.
Where is ALZpath headquartered?
ALZpath is based in Carlsbad, California, United States.
How many employees does ALZpath have?
ALZpath is in the 1-10 employee band.
When was ALZpath founded?
ALZpath was founded in 2020.
How does ALZpath's funding compare to other Biotechnology startups?
ALZpath's latest round of $8.4M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's ALZpath Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ALZpath is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.